跳至主要内容
临床试验/JPRN-jRCTs032210221
JPRN-jRCTs032210221已完成2 期

Effects and safety of prophylactic compression therapy for taxane-induced peripheral neuropathy

Hiroko Bando0 个研究点目标入组 10 人开始时间: 2021年8月4日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 70age old(—)
性别
Female

入选标准

  • 1 Patients aged between 20 and 70 at the time of consent
  • 2 Patients with stage1-3C primary breast cancer
  • 3 Patients receiving taxane anticancer drugs in perioperative che
  • motherapy for primary breast cancer
  • 4 Eastern Cooperative Oncology Group Performance status 0 or 1
  • 5 Written informed consent

排除标准

  • 1.Patients with peripheral neuropathy in the upper or lower limbs
  • 2.Patients with arterial blood circulation disorders such asa arteriosclerosis obliterans
  • 3.Patients with infectious or inflammatory diseases on the skin aroung the upper and lower limbs
  • 4.Patients diagnosed with acute within 1 year prior screening
  • 5.Patients with severe congestive heart failure
  • 6.Patients with compression stockings or latex allergy used in this study
  • 7.Patients of extremely small or large hands that deviate from the size range of surgical gloves
  • 8.Patients of extremely small or large lower limbs that deviate frome the range of medical compression stocings
  • 9.Patients with thrombophlebitis of the superficial veins of the lower extremeties
  • 10.Other patients that the research doctor deems inappropriate

研究者

发起方
Hiroko Bando

相似试验

Preventive effect of compression therapy on CIP | 临床试验